Mepolizumab reduced exacerbations in children with exacerbation-prone eosinophilic asthma
1. There was a 27% reduction of severe asthma exacerbations in children treated with mepolizumab compared to control. 2. There ...
1. There was a 27% reduction of severe asthma exacerbations in children treated with mepolizumab compared to control. 2. There ...
1. Provision of an inhaled glucocorticoid and instruction on its use led to a significantly lower rate of severe asthma ...
1. Treatment of moderate-to-severe asthma with itepekimab was shown to demonstrate greater asthma control than treatment with placebo. 2. Treatment ...
1. Subcutaneous tezepelumab treatment reduced the rate of annual asthma exacerbations in patients with severe asthma compared to the placebo ...
Maintenance inhaled corticosteroid therapy is effective for preventing severe asthma exacerbations in patients with mild to moderate asthma at baseline. ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.